Industry Symposia

Click on each title to see the details

GSK Symposium: Modifying the natural history of LN: from theory to clinical practice

Thursday, 27 April

Room America

10.30 – 11.30

10:30 – 10:45 Why consider Belimumab as SOC in LN? Disease modification concept – PROF ROGER A LEVY, GME GSK

10:45 – 11:00 From Concept to real world: Clinical Case Discussion (patient profile: LN) – PROF ANA MALVAR, ARG

11:00 – 11:15 What do the recommendations for Lupus Nephritis say? – PROF EDGARD TORRES, BRA

11:15 – 11:30 Q&A – ALL

Moderator: PROF ROGER LEVY, GME GSK (Brazil)

Roger A. Levy
Roger A. Levy Brazil
Rheumatologist. GSK Global Medical Expert. Vascular Diseases Committee Coordinator, of the Brazilian Society of Rheumatology.
Ana Valeria Malvar Perrin
Ana Valeria Malvar Perrin Argentina
Medical Specialist in Nephrology and acid-base, electrolyte and fluid homeostasis Professor: School of Medicine, Nephrology...
Edgard Torres
Edgard Torres Brazil
Adjunct Professor at Escola Paulista de Medicina, Federal University of São Paulo. Lupus Commission Coordinator of the Brazilian Society of...

GSK Symposium: Herpes zoster and the rheumatic patient: Impact and prevention

Thursday, 27 April

Room Galapagos

13.30 – 14.30

Moderator: Jesse Reis Alves (Brazil), GSK Vaccines Medical Manager.

Clovis Arns da Cunha
Clovis Arns da Cunha Brazil
Infectious disease physician, currently Professor of Infectious Diseases at UFPR.
Viviane Angelina De Souza
Viviane Angelina De Souza Brazil
Adjunct Professor of Rheumatology/UFJF, Scientific Director of the Sociedade Mineira de Reumatologia and Coordinator of the Commission on...

New approaches in the treatment of Psoriatic Arthritis

Thursday, 27 April

Room Oceania B

13.30 – 14.30

Unmet needs in the management of Psoriatic Arthritis – Dr Roberto Ranza

Risankizumab and Upadacitinib in the treatment of Psoriatic Arthritis – Dr Dennis McGonagle

Q&A – Dr Ranza & Dr McGonagle – all

Dennis McGonagle
Dennis McGonagle UK
Leeds Institute of Rheumatic & Musculoskeletal Medicine, University of Leeds, Leeds, UK
Roberto Ranza
Roberto Ranza Argentina
Rheumatology residence program and Rheumatology department chief at Universidade Federal de Uberlândia (UFU)

Treatment target: long term and RWE data for remission and LDA with baricitinib in RA

Thursday, 27 April

Room Oceania A

13.30 – 14.30
  • Lecture – Prof. Dr. Ricardo Blanco
  • Q&A – Dr. Dawton Torigoe

Lecture will be in Spanish and local translation will be available.

Ricardo Blanco
Ricardo Blanco Spain
Chairman and Principal Investigator of the research group, Epidemiology, Genetics and Arteriosclerosis in Systemic Inflammatory Diseases...
Dawton Yukito Torigoe
Dawton Yukito Torigoe Brazil
Head of the Rheumatology Discipline at Santa Casa de São Paulo. PhD in Rheumatology from FMUSP.

10 years with infliximab biosimilar in rheumatic treatment: what is the next evolution?

Thursday, 27 April

Room Oceania B

16.15 – 17.15

16:15 – 16:25 Welcome Remarks – Dr. Salim Benkhalifa (France)

16:25 – 16:45 Biosimilarity and Beyond: Now and then of Infliximab – Dr. Valderilio Feijó Azevedo (Brazil)

10 years recap studies of infliximab biosimilar including pivotal and real-world studies.

16:45 – 17:05 Redefining Infliximab: the era of subcutaneous infliximab – Prof. Yannick Allanore (France)

Introduction of subcutaneous infliximab pivotal studies

17:05 – 17:15 Closing Remarks / Q&A – Dr. Salim Benkhalifa (France)

Moderator: Dr. Salim Benkhalifa (Francia)

Yannick Allanore
Yannick Allanore France
Director of the Musculo-skeletal academic department of APHP. Centre Université de Paris. Head of department of Rheumatology, Paris Descartes...
Valderilio Feijó Azevedo
Valderilio Feijó Azevedo Brazil
Universidade Federal de Paraná Rheumatology Professor. Head of Rheumatology Service at Universidade Federal do Paraná...

Saphnelo® (anifrolumab) in SLE: thinking long-term for our patients

Thursday, 27 April

Room Oceania A

16.15 – 17.15

16:15 – 16:30 Welcome and introductions (Professor Odirlei Monticielo)

16:30 – 16:40 Balancing the benefits and risks of GCs in SLE (Professor Odirlei Monticielo)

16:40 – 16:55 Building the picture of treatment with Saphnelo – insights from long-term data (Doctor Grace Wright)

16:55 – 17:10 Striving for comprehensive control – a case in focus (Doctor Sheetal Desai)

17:10 – 17:15 Summary and close (Professor Odirlei Monticielo)

Sheetal Desai
Sheetal Desai USA
Doctor Sheetal Desai is a Clinical Professor of Medicine and Chief of the Division of Rheumatology at UC Irvine’s School of Medicine, with over...
Odirlei Monticielo
Odirlei Monticielo Brazil
Professor Odirlei Monticielo is a rheumatology specialist and the Chief of the Division of Rheumatology at Hospital de Clínicas de Porto Alegre...
Grace Wright
Grace Wright USA
Doctor Grace Wright is a consultant rheumatologist in New York. Dr Wright earned her medical and doctorate degrees at the New York...

Spondylitis pain, are we really in control?

Thursday, 27 April

Room Galapagos

16.15 – 17.15

16:15 Welcome and introduction. Speaker

16:20 Spondylitis pain, are we really in control?. Speaker

17:10 Q&A. Speaker

Atul Deodhar
Atul Deodhar USA
Atul A. Deodhar, MD, is Professor of Medicine and Medical Director of rheumatology clinics in Oregon Health & Science University, Portland. Dr. Deodhar...

Meet the Experts: Managing difficult SLE cases

Friday, 28 April

Room Aruba

08.00 – 09.00





Roger A. Levy
Roger A. Levy Brazil
Rheumatologist. GSK Global Medical Expert. Vascular Diseases Committee Coordinator, of the Brazilian Society of Rheumatology.
Ana Patricia Nascimento
Ana Patricia Nascimento Brazil
Dr Ana Patricia Nascimento
Marina Scolnik
Marina Scolnik Argentina
Medical specialist in Internal Medicine and Rheumatology. Italian Hospital of Buenos Aires. Master in Clinical Effectiveness. Member of GLADEL
Luciana Seguro
Luciana Seguro Brazil
Rheumatologist from Lupus Group at HCFMUSP. Member of the Lupus Committee at the Brazilian Society of Rheumatology..

What is the best therapeutic choice for my patient with PSA or axSpA?

Friday, 28 April

Room America

10.30 – 11.30
  • PSA discussion – Dr. Vinicius Domingues
  • axSpA discussion – Prof. Xenofon Baraliakos
  • Q&A – Dr. Rodrigo Luppino

Moderator: Dr. Rodrigo Luppino Assad (Brazil)

Xenofon Baraliakos
Xenofon Baraliakos Germany
Chief of Department, Rheumatology, Ruhr-University Bochum, Germany.
Vinicius Domingues
Vinicius Domingues USA
Graduated from Estácio de Sá Medical School (Brazil); Internal Medicine residency at Weill Cornell Medical Center (NYP / NY)...
Rodrigo Luppino
Rodrigo Luppino Brazil
Physician at the Hospital das Clínicas of the Faculty of Medicine of Ribeirão Preto and at CEDMAC (Center for High Complexity Medicines)...

Upadacitinib in Rheumatoid Arthritis and its Role in Helping Patients Reach Treatment Goals

Friday, 28 April

Room Oceania B

16.15 – 17.15

Unmet needs in RA management: Is there a treatment goal gap? – Dr Ricardo Xavier

Upadacitinib in the treatment of Rheumatoid Arthritis – Dr Eduardo Mysler

Q&A – Dr Xavier & Dr Mysler & all

Eduardo Mysler
Eduardo Mysler Argentina
Director of the medical research organization OMI (Organizacion Medica de Investigacion) – Buenos Aires, Argentina. Member of the American...
Ricardo Xavier
Ricardo Xavier Brazil
Full Professor of Rheumatology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. President of the Brazilian Society of Rheumatology...